Reinhart Partners’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-2,555
Closed -$430K 104
2018
Q1
$430K Buy
2,555
+175
+7% +$29.4K 0.04% 89
2017
Q4
$389K Buy
2,380
+530
+29% +$95.1K 0.04% 95
2017
Q3
$379K Sell
1,850
-140
-7% -$32.6K 0.04% 95
2017
Q2
$484K Buy
+1,990
New +$468K 0.05% 84

Other funds holding AGN

Reinhart Partners's AGN Position: Q2 2018 in Review

Reinhart Partners sold out of Allergan plc (AGN) in Q2 2018, closing a stake of 2,555 shares — an estimated $430K sold.

Reinhart Partners first reported a position in AGN in Q2 2017 and held it in 4 quarters. The position peaked at $484K in Q2 2017. 1,044 funds tracked by Wall St. Rank hold AGN as of Q2 2018.

  • Reinhart Partners reported no remaining Allergan plc position as of Q2 2018 after selling out during the quarter.
  • Reinhart Partners sold 2,555 Allergan plc shares in Q2 2018, an estimated $430K.
  • Reinhart Partners first reported a position in Allergan plc in Q2 2017 and held it in 4 quarters.
  • Reinhart Partners's Allergan plc position peaked at $484K in Q2 2017.
  • 1,044 funds tracked by Wall St. Rank held Allergan plc as of Q2 2018.

Based on Reinhart Partners's 13F filing for Q2 2018, filed 23 Jul 2018.